Comments
Sun Pharma Advanced Research Company today reported a standalone net loss of Rs 18.91 crore for the quarter ended December 31, 2014.
The company had posted a net profit if Rs 30.97 crore for the corresponding period of the previous fiscal, Sun Pharma Advanced Research Company (SPARC) said in a filing to BSE.
Standalone total income of the company stood at Rs 32.21 crore for the quarter under consideration. It was Rs 65.07 crore for the same period year ago, it added.
Shares of Sun Pharma Advanced Research Company today closed at Rs 328.40 on BSE, down 5.94 per cent from previous close.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.